The Lancet
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
✓ Free legal copy found
Preprint, hosted by Yonsei University (ir.ymlib.yonsei.ac.kr)
This is the authors’ own version from before peer review, so it may differ from the published paper.
Read it free at ir.ymlib.yonsei.ac.kr →Licence: CC BY-NC-ND
DOI: 10.1016/s0140-6736(10)61121-x · Publisher: Elsevier BV